Renaissance Technologies - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 58 filers reported holding HOMOLOGY MEDICINES INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q4 2023$106
-49.8%
174,600
-3.0%
0.00%
Q3 2023$211
-20.4%
180,000
-39.8%
0.00%
Q2 2023$265
-16.7%
299,100
-3.3%
0.00%
Q1 2023$318
-24.3%
309,217
-7.2%
0.00%
-100.0%
Q4 2022$420
-99.9%
333,153
-12.1%
0.00%0.0%
Q3 2022$610,000
+24.5%
379,100
+52.4%
0.00%0.0%
Q2 2022$490,000
-31.1%
248,800
+6.3%
0.00%0.0%
Q1 2022$711,000
+33.9%
234,000
+60.3%
0.00%0.0%
Q4 2021$531,000
-61.2%
145,993
+61.9%
0.00%0.0%
Q2 2020$1,370,000
+63.9%
90,200
+67.7%
0.00%0.0%
Q1 2020$836,00053,7860.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q4 2023
NameSharesValueWeighting ↓
VV Manager LLC 770,845$17,236,0007.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,227,035$116,877,0004.68%
RTW INVESTMENTS, LP 1,633,491$36,525,0003.40%
Vivo Capital, LLC 1,159,742$25,932,0003.31%
Casdin Capital, LLC 350,000$7,826,0001.34%
Temasek Holdings (Private) Ltd 3,220,293$72,006,0000.50%
Rock Springs Capital Management LP 450,000$10,062,0000.48%
SPHERA FUNDS MANAGEMENT LTD. 161,000$3,600,0000.41%
COURAGE CAPITAL MANAGEMENT LLC 10,000$224,0000.18%
Global Thematic Partners, LLC 134,776$3,014,0000.16%
View complete list of HOMOLOGY MEDICINES INC shareholders